News and Events

Programs and providers of Obstetrics and Gynecology at Weill Cornell Medicine are often the focus of news stories and features appearing in major national media. We invite you to review some stories that typify the breakthrough accomplishments of our remarkable team and highlight the impact our care has had on patient’s lives.

Despite Obstacles, Women Are Uniquely Positioned to Flourish in Medicine

leadership

Thriving as a woman in academic medicine requires blending resilience, authenticity and community while nurturing passions and people, said Dr. Helen W. Boucher, dean of Tufts University School of Medicine and chief academic officer of Tufts Medicine, in her keynote address April 10 for Weill Cornell Medicine’s seventh annual Diversity Week.   

Dr. Boucher, who is also a professor of medicine at Tufts, delivered the Women in Medicine and Science lecture, “Off the Beaten Path: Thriving in Academic Medicine,” in Uris Auditorium. Her speech was part of a series of events to mark Diversity Week, which celebrates Weill Cornell Medicine’s commitment to greater equity, diversity, and inclusion in academic medicine and health care.

Weaving together data and personal reflections, Dr. Boucher contended that while women in medicine have made meaningful progress over the past several decades, significant gaps and challenges remain, from pay inequity to underrepresentation in senior roles. She highlighted the need for multidirectional mentorship as well as the importance of saying yes to opportunities even amid uncertainty.

New Strategy May Enable Cancer Monitoring from Blood Tests Alone

gloved hand holding lab tube

A new, error-corrected method for detecting cancer from blood samples is much more sensitive and accurate than prior methods and may be useful for monitoring disease status in patients following treatment, according to a study by Weill Cornell Medicine and New York Genome Center investigators. The method, based on whole-genome sequencing of DNA, also represents an important step toward the goal of routine blood test-based screening for early cancer detection.

In the study, published Apr. 11 in Nature Methods, the researchers benchmarked the cancer-detection performance of a new commercial sequencing platform from Ultima Genomics. They demonstrated that a low-cost platform such as this one enables a very high “depth” of coverage—a measure of the sequencing data quality—allowing investigators to detect extremely low concentrations of circulating tumor DNA. Adding an error-correcting method greatly improved the accuracy of the technique.

Awards Recognize Diversity Champions Across Weill Cornell Medicine

Diversity awards 2025

Weill Cornell Medicine’s Celebration of Diversity honored leaders who go beyond their official roles, dedicating time, energy and empathy to build inclusive environments. The ceremony, part of the institution’s seventh annual Diversity Week, was held April 7 in Griffis Faculty Club.

“This is one of the most important evenings of the year at Weill Cornell Medicine,” said  Dr. Robert A. Harrington, the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine in opening remarks. “We are here to recognize the people who tirelessly throughout the year make sure that we are a community that has as one of its core values a real commitment to diversity, equity, inclusion, justice and belonging.”

Dr. Etingin Diversity Award

Left to right: Dr. Rache Simmons, Dr. Orli Etingin and Dr. Robert Harrington